About

No biography available yet.

Research Focus

Key Achievements

7
H-Index
9
Papers
240
Total Citations
27
Avg Citations/Paper
🏆 Most Cited Paper
Safety and effectiveness of pembrolizumab combined with paclitaxel and cisplatin as neoadjuvant therapy followed by surgery for locally advanced resectable (stage III) esophageal squamous cell carcinoma: a study protocol for a prospective, single-arm, single-center, open-label, phase-II trial (Keystone-001)
62 citations · 2022
📈 Most Prolific Year: 2020 (4 Papers)
🤝 Key Collaborators: 62
🏛 Institutions: Tianjin Medical University Cancer Institute and Hospital, Sun Yat-sen University

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9

Key Collaborators

Not generated yet